G. S. Kulkarni, O. W. Hakenberg, J. E. Gschwend, G. Thalmann, W. Kassouf, A. Kamat and A. Zlotta, “An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-Grade T1 (Previously T1G3) Bladder Cancer,” European Urology, Vol. 57, No. 1, 2010, pp. 60-70. doi:10.1016/j.eururo.2009.08.024

has been cited by the following article:

• TITLE: Clinicopathological Analysis of Patients with Nonmuscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy

  AUTHORS: Naotaka Nishiyama, Hiroshi Kitamura, Masatoshi Mutoh, Masahiro Yanase, Hiroyuki Iwaki, Tadashi Hasegawa, Taiji Tsukamoto

  KEYWORDS: Clinicopathological Examination; Nonmuscle-Invasive Bladder Cancer; Radical Cystectomy, Pathological Upstaging

  JOURNAL NAME: Surgical Science, Vol.3 No.7, July 19, 2012

  ABSTRACT: Objectives: Surgical specimens obtained at the time of the last transurethral resection of bladder tumor (TURBT) for patients with nonmuscle-invasive bladder cancer (NMIBC) who underwent radical cystectomy were retrospectively evaluated in order to investigate the relationship between pathological variation and upstaging of NMIBC. Methods and Materials: Twenty patients (19 men, 1 woman; aged 69.4 ± 12.1 (mean ± SD) years) diagnosed with NMIBC underwent radical cystectomy during follow-up. Results: Five of the 20 patients (25%) had pathological upstaging in the radical cystectomy specimens. There was a statistical association between pathological upstaging and cancer death (p = 0.002). There were three patterns of pathological variation in the upstaged specimens: 1) in patients with BCG-resistant NMIBC, urothelial carcinoma invaded through the lamina propria; 2) urothelial carcinoma showed diffuse invasion beyond the deep lamina propria, and the cancer cells had infiltrated as single cells and formed nodules; 3) TURBT specimens showed a micropapillary variant. Conclusions: Since these pathological variations correlated with pathological upstaging, they may provide an indication for cystectomy in NMIBC patients.